|
Levesque, M C; Haynes, B F (2001) Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma. J Immunol 166:188-96
|
|
Levesque, M C; Mackin, D A; Fleming, J A et al. (2000) Serum levels of soluble CD44 in primary Sjogren's syndrome. J Rheumatol 27:1444-9
|
|
Levesque, M C; Haynes, B F (1999) TNFalpha and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44. Cell Immunol 193:209-18
|
|
Levesque, M C; Ward, F E; Jeffery, D R et al. (1999) Interferon-beta1A-induced polyarthritis in a patient with the HLA-DRB1*0404 allele. Arthritis Rheum 42:569-73
|
|
Levesque, M C; Hobbs, M R; Anstey, N M et al. (1999) Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. J Infect Dis 180:1994-2002
|
|
Levesque, M C; Haynes, B F (1997) Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13. J Immunol 159:6184-94
|
|
Levesque, M C; Haynes, B F (1996) In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J Immunol 156:1557-65
|
